UBE3C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.991400E-01
Normal-vs-Stage2
7.621200E-01
Normal-vs-Stage3
8.475900E-02
Normal-vs-Stage4
8.293200E-01
Stage1-vs-Stage2
7.530000E-01
Stage1-vs-Stage3
4.644500E-02
Stage1-vs-Stage4
8.509400E-01
Stage2-vs-Stage3
6.373700E-02
Stage2-vs-Stage4
9.506400E-01
Stage3-vs-Stage4
2.713400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.513800E-01
Normal-vs-AfricanAmerican
5.191400E-01
Normal-vs-Asian
9.201200E-01
Caucasian-vs-AfricanAmerican
4.497600E-01
Caucasian-vs-Asian
5.583800E-01
AfricanAmerican-vs-Asian
4.172800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.868200E-01
Normal-vs-Female
7.735000E-01
Male-vs-Female
6.146200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.821200E-01
Normal-vs-Age(41-60Yrs)
4.768400E-01
Normal-vs-Age(61-80Yrs)
9.936000E-01
Normal-vs-Age(81-100Yrs)
9.632600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.847200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.321200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.505000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.397850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.630600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.448800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.752400E-01
Normal-vs-Daily Drinker
8.698000E-01
Normal-vs-Weekly Drinker
7.410600E-01
Normal-vs-Occasional Drinker
6.394600E-01
Normal-vs-Social Drinker
4.297600E-01
Non Drinker-vs-Daily Drinker
9.661400E-01
Non Drinker-vs-Weekly Drinker
3.284200E-01
Non Drinker-vs-Occasional Drinker
2.544600E-01
Non Drinker-vs-Social Drinker
5.167900E-02
Daily Drinker-vs-Weekly Drinker
3.637000E-01
Daily Drinker-vs-Occasional Drinker
2.819000E-01
Daily Drinker-vs-Social Drinker
7.492500E-02
Weekly Drinker-vs-Occasional Drinker
9.276400E-01
Weekly Drinker-vs-Social Drinker
4.861600E-01
Occasional Drinker-vs-Social Drinker
3.105000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.362200E-01
Normal-vs-Grade 2
9.855800E-01
Normal-vs-Grade 3
9.331800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.262200E-01
Grade 1-vs-Grade 3
3.225600E-02
Grade 1-vs-Grade 4
9.362200E-01
Grade 2-vs-Grade 3
2.208600E-01
Grade 2-vs-Grade 4
9.855800E-01
Grade 3-vs-Grade 4
9.331800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.777000E-01
Normal-vs-NonDiabetic
9.046800E-01
Diabetic-vs-NonDiabetic
8.056400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.366400E-01
Normal-vs-NoPancreatitis
9.367400E-01
Pancreatitis-vs-NoPancreatitis
3.285800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.833800E-01
Normal-vs-N1
7.686400E-01
N0-vs-N1
3.295400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.659000E-01
Normal-vs-TP53-NonMutant
7.494600E-01
TP53-Mutant-vs-TP53-NonMutant
1.836750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
